It has been a difficult few months for the Canadian cystic fibrosis community. While our country is widely known for being a world leader when it comes to publicly funded cystic fibrosis care and healthcare in general, the same cannot be said for its position on pharmacare. Many Americans will be surprised to learn that...
Continue reading...

I never had asthma until a year and a half ago. One night, Gunnar and I were getting ready to go to bed in his bedroom back home in Long Island, like we had for years. Out of nowhere, my throat and chest started to feel very tight. “Oh no…” I thought, “I’m coming down...
Continue reading...

Amy is back with the final installment of her miniseries Coverage Tips for Costly Drugs. Today she is going to take you through the alternative cost assistance programs, which may apply to different populations. It’s important to note that what is discussed below may not apply to you depending on your coverage situation. It is...
Continue reading...

Amy is back with the second installment of her miniseries Coverage Tips for Costly Drugs. Today she is going to take you through the Medicare landscape, which as you will see below can be a bit tricky. It’s important to note that what is discussed below may not apply to you depending on your coverage...
Continue reading...

Amy, who generously penned our Drug Development Wednesday series, is back to discuss coverage options and payment strategies in the United States. This guest column will include three blogs and discuss different ways people may face easy access to medications or challenging and costly hurdles. It’s important to note that what is discussed below may...
Continue reading...